Genetic Loss of LCK Kinase Leads to Acceleration of Chronic Lymphocytic Leukemia

Most patients with chronic lymphocytic leukemia (CLL) exhibit an indolent disease course and unresponsive B cell receptors (BCRs) exemplified by an anergic phenotype of their leukemic cells. In up to 5% of patients, CLL transforms from an indolent subtype to an aggressive form of B cell lymphoma (Ri...

Full description

Bibliographic Details
Main Authors: Melanie Märklin, Alexander R. Fuchs, Claudia Tandler, Jonas S. Heitmann, Helmut R. Salih, Joseph Kauer, Leticia Quintanilla-Martinez, Stefan Wirths, Hans-Georg Kopp, Martin R. Müller
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-09-01
Series:Frontiers in Immunology
Subjects:
CLL
LCK
Online Access:https://www.frontiersin.org/article/10.3389/fimmu.2020.01995/full